|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 422 for Ido1

<< First    < Previous  |  Next >    Last >>
0.048s
Type Details Score
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: cattle
Gene
Type: gene
Organism: zebrafish
Gene
Type: gene
Organism: macaque, rhesus
Gene
Type: gene
Organism: frog, western clawed
Gene
Type: gene
Organism: rat
Gene
Type: gene
Organism: dog, domestic
Gene
Type: gene
Organism: chimpanzee
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Publication  
First Author: Mondal A
Year: 2016
Journal: EBioMedicine
Title: IDO1 is an Integral Mediator of Inflammatory Neovascularization.
Volume: 14
Pages: 74-82
Publication
First Author: Takamatsu M
Year: 2013
Journal: J Immunol
Title: IDO1 plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice.
Volume: 191
Issue: 6
Pages: 3057-64
Publication  
First Author: Zhou C
Year: 2020
Journal: Molecules
Title: Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors.
Volume: 25
Issue: 6
Publication
First Author: Matino D
Year: 2015
Journal: J Clin Invest
Title: IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII.
Volume: 125
Issue: 10
Pages: 3766-81
Publication  
First Author: Amobi-McCloud A
Year: 2021
Journal: Front Immunol
Title: IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation.
Volume: 12
Pages: 678999
Publication  
First Author: Ju JM
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: IDO1 scavenges reactive oxygen species in myeloid-derived suppressor cells to prevent graft-versus-host disease.
Volume: 118
Issue: 10
Publication
First Author: Chen B
Year: 2020
Journal: Cancer Immunol Res
Title: Interferon-Induced IDO1 Mediates Radiation Resistance and Is a Therapeutic Target in Colorectal Cancer.
Volume: 8
Issue: 4
Pages: 451-464
Publication  
First Author: Merlo LMF
Year: 2020
Journal: Front Immunol
Title: Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses.
Volume: 11
Pages: 1861
Publication
First Author: Thaker AI
Year: 2013
Journal: Gastroenterology
Title: IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
Volume: 145
Issue: 2
Pages: 416-25.e1-4
Publication
First Author: De Luca A
Year: 2013
Journal: PLoS Pathog
Title: IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis.
Volume: 9
Issue: 7
Pages: e1003486
Publication
First Author: Put K
Year: 2016
Journal: PLoS One
Title: IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
Volume: 11
Issue: 2
Pages: e0150075
Publication
First Author: Fukunaga M
Year: 2012
Journal: J Histochem Cytochem
Title: Studies on tissue and cellular distribution of indoleamine 2,3-dioxygenase 2: the absence of IDO1 upregulates IDO2 expression in the epididymis.
Volume: 60
Issue: 11
Pages: 854-60
Publication
First Author: Laugeray A
Year: 2016
Journal: PLoS One
Title: Chronic Treatment with the IDO1 Inhibitor 1-Methyl-D-Tryptophan Minimizes the Behavioural and Biochemical Abnormalities Induced by Unpredictable Chronic Mild Stress in Mice - Comparison with Fluoxetine.
Volume: 11
Issue: 11
Pages: e0164337
Publication  
First Author: Ren J
Year: 2022
Journal: Front Genet
Title: Identifying Antidepressant Effects of Brain-Derived Neurotrophic Factor and IDO1 in the Mouse Model Based on RNA-Seq Data.
Volume: 13
Pages: 890961
Publication
First Author: Bishnupuri KS
Year: 2019
Journal: Cancer Res
Title: IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.
Volume: 79
Issue: 6
Pages: 1138-1150
Publication
First Author: Torosyan R
Year: 2021
Journal: Cell Rep
Title: Hypoxic preconditioning protects against ischemic kidney injury through the IDO1/kynurenine pathway.
Volume: 36
Issue: 7
Pages: 109547
Publication  
First Author: Li Y
Year: 2021
Journal: Free Radic Biol Med
Title: Indoleamine 2, 3-dioxygenase 1 aggravates acetaminophen-induced acute liver failure by triggering excess nitroxidative stress and iron accumulation.
Volume: 172
Pages: 578-589
Publication
First Author: Jrad-Lamine A
Year: 2013
Journal: PLoS One
Title: Indoleamine 2,3-dioxygenase 1 (ido1) is involved in the control of mouse caput epididymis immune environment.
Volume: 8
Issue: 6
Pages: e66494
Publication
First Author: Newman AC
Year: 2021
Journal: Mol Cell
Title: Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells.
Volume: 81
Issue: 11
Pages: 2290-2302.e7
Publication
First Author: Mondanelli G
Year: 2017
Journal: Immunity
Title: A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells.
Volume: 46
Issue: 2
Pages: 233-244
Publication
First Author: Mo C
Year: 2021
Journal: Cell Death Dis
Title: Indoleamine 2,3-dioxygenase 1 limits hepatic inflammatory cells recruitment and promotes bile duct ligation-induced liver fibrosis.
Volume: 12
Issue: 1
Pages: 16
Publication  
First Author: Mazarei G
Year: 2013
Journal: Exp Neurol
Title: The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain.
Volume: 249
Pages: 144-8
Publication  
First Author: Mannarino MR
Year: 2023
Journal: Front Immunol
Title: A tryptophan metabolite prevents depletion of circulating endothelial progenitor cells in systemic low-grade inflammation.
Volume: 14
Pages: 964660
Publication  
First Author: Davison LM
Year: 2019
Journal: Front Immunol
Title: Limited Effect of Indolamine 2,3-Dioxygenase Expression and Enzymatic Activity on Lupus-Like Disease in B6.Nba2 Mice.
Volume: 10
Pages: 2017
Publication
First Author: Juda MB
Year: 2019
Journal: Epilepsia
Title: Indoleamine 2,3-dioxygenase 1 deletion promotes Theiler's virus-induced seizures in C57BL/6J mice.
Volume: 60
Issue: 4
Pages: 626-635
Publication
First Author: Kim H
Year: 2012
Journal: J Clin Invest
Title: Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression.
Volume: 122
Issue: 8
Pages: 2940-54
Publication
First Author: Peng K
Year: 2010
Journal: Infect Immun
Title: Indoleamine 2,3-dioxygenase 1 is a lung-specific innate immune defense mechanism that inhibits growth of Francisella tularensis tryptophan auxotrophs.
Volume: 78
Issue: 6
Pages: 2723-33
Publication  
First Author: Taguchi A
Year: 2014
Journal: Neurosci Lett
Title: Indoleamine 2,3-dioxygenase 1 is upregulated in activated microglia in mice cerebellum during acute viral encephalitis.
Volume: 564
Pages: 120-5
Publication  
First Author: Nguyen DT
Year: 2023
Journal: JCI Insight
Title: The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression.
Volume: 8
Issue: 1
Publication
First Author: Vogel CF
Year: 2008
Journal: Biochem Biophys Res Commun
Title: Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase.
Volume: 375
Issue: 3
Pages: 331-5
Publication
First Author: Gonzalez-Pena D
Year: 2016
Journal: PLoS One
Title: Differential Transcriptome Networks between IDO1-Knockout and Wild-Type Mice in Brain Microglia and Macrophages.
Volume: 11
Issue: 6
Pages: e0157727
Publication
First Author: Vidal C
Year: 2015
Journal: Stem Cells
Title: The kynurenine pathway of tryptophan degradation is activated during osteoblastogenesis.
Volume: 33
Issue: 1
Pages: 111-21
Publication
First Author: Huang T
Year: 2022
Journal: Nat Commun
Title: Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR/STAT3/IL-6 signaling.
Volume: 13
Issue: 1
Pages: 3489
Publication
First Author: Metghalchi S
Year: 2015
Journal: Cell Metab
Title: Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production.
Volume: 22
Issue: 3
Pages: 460-71
Publication
First Author: Metz R
Year: 2014
Journal: Int Immunol
Title: IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.
Volume: 26
Issue: 7
Pages: 357-67
Publication
First Author: Zhong W
Year: 2017
Journal: Oncotarget
Title: Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation.
Volume: 8
Issue: 25
Pages: 40486-40500
Publication
First Author: Merlo LMF
Year: 2014
Journal: J Immunol
Title: IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis.
Volume: 192
Issue: 5
Pages: 2082-2090
Publication
First Author: Bessede A
Year: 2014
Journal: Nature
Title: Aryl hydrocarbon receptor control of a disease tolerance defence pathway.
Volume: 511
Issue: 7508
Pages: 184-90
Publication
First Author: Lightman SM
Year: 2021
Journal: Immunity
Title: Indoleamine 2,3-dioxygenase 1 is essential for sustaining durable antibody responses.
Volume: 54
Issue: 12
Pages: 2772-2783.e5
Publication
First Author: Huang L
Year: 2016
Journal: PLoS Pathog
Title: Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase.
Volume: 12
Issue: 5
Pages: e1005615
Publication  
First Author: Too LK
Year: 2014
Journal: Behav Brain Res
Title: The kynurenine pathway contributes to long-term neuropsychological changes in experimental pneumococcal meningitis.
Volume: 270
Pages: 179-95
Publication
First Author: Tsai CY
Year: 2018
Journal: Int Immunol
Title: Bystander inhibition of humoral immune responses by Epstein-Barr virus LMP1.
Volume: 30
Issue: 12
Pages: 579-590
Publication
First Author: Takamatsu M
Year: 2015
Journal: Cancer Sci
Title: Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice.
Volume: 106
Issue: 8
Pages: 1008-15
Publication
First Author: Smith C
Year: 2012
Journal: Cancer Discov
Title: IDO is a nodal pathogenic driver of lung cancer and metastasis development.
Volume: 2
Issue: 8
Pages: 722-35
Publication  
First Author: Too LK
Year: 2016
Journal: Behav Brain Res
Title: Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function.
Volume: 312
Pages: 102-17
Publication
First Author: Kumar S
Year: 2017
Journal: J Leukoc Biol
Title: Hepatic stellate cells increase the immunosuppressive function of natural Foxp3+ regulatory T cells via IDO-induced AhR activation.
Volume: 101
Issue: 2
Pages: 429-438
Publication  
First Author: Arora A
Year: 2022
Journal: Int J Mol Sci
Title: Genetic Deficiency of Indoleamine 2,3-dioxygenase Aggravates Vascular but Not Liver Disease in a Nonalcoholic Steatohepatitis and Atherosclerosis Comorbidity Model.
Volume: 23
Issue: 9
Publication  
First Author: Mo C
Year: 2020
Journal: Free Radic Biol Med
Title: Mutual antagonism between indoleamine 2,3-dioxygenase 1 and nuclear factor E2-related factor 2 regulates the maturation status of DCs in liver fibrosis.
Volume: 160
Pages: 178-190
Publication  
First Author: Manni G
Year: 2020
Journal: Front Immunol
Title: Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine.
Volume: 11
Pages: 292
Publication  
First Author: Mondanelli G
Year: 2021
Journal: Front Immunol
Title: Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity.
Volume: 12
Pages: 713989
Publication
First Author: Mondanelli G
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation.
Volume: 117
Issue: 7
Pages: 3848-3857
Publication
First Author: Gao L
Year: 2021
Journal: Aging (Albany NY)
Title: Blockade of Indoleamine 2, 3-dioxygenase 1 ameliorates hippocampal neurogenesis and BOLD-fMRI signals in chronic stress precipitated depression.
Volume: 13
Issue: 4
Pages: 5875-5891
Publication
First Author: Mazarei G
Year: 2013
Journal: J Neurochem
Title: Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease.
Volume: 127
Issue: 6
Pages: 852-67
Publication  
First Author: Hoffmann D
Year: 2020
Journal: Front Immunol
Title: Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance.
Volume: 11
Pages: 601759
Publication
First Author: Sharma MD
Year: 2021
Journal: Immunity
Title: Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity.
Volume: 54
Issue: 10
Pages: 2354-2371.e8
Publication
First Author: Gargaro M
Year: 2022
Journal: Immunity
Title: Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication.
Volume: 55
Issue: 6
Pages: 1032-1050.e14
Publication
First Author: Mittal D
Year: 2013
Journal: J Invest Dermatol
Title: Indoleamine 2,3-dioxygenase activity contributes to local immune suppression in the skin expressing human papillomavirus oncoprotein e7.
Volume: 133
Issue: 12
Pages: 2686-2694
Publication
First Author: Huang L
Year: 2013
Journal: PLoS One
Title: Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infection.
Volume: 8
Issue: 6
Pages: e66546
Publication  
First Author: Moyer BJ
Year: 2016
Journal: Toxicol Appl Pharmacol
Title: Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
Volume: 300
Pages: 13-24
Publication
First Author: Bhutia YD
Year: 2015
Journal: Biochim Biophys Acta
Title: Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells.
Volume: 1848
Issue: 2
Pages: 453-62
Publication
First Author: Sundaram K
Year: 2022
Journal: Theranostics
Title: Garlic exosome-like nanoparticles reverse high-fat diet induced obesity via the gut/brain axis.
Volume: 12
Issue: 3
Pages: 1220-1246
Publication
First Author: Alvarado DM
Year: 2019
Journal: Gastroenterology
Title: Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota.
Volume: 157
Issue: 4
Pages: 1093-1108.e11
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus caroli
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus pahari
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus spretus
Publication
First Author: Baban B
Year: 2004
Journal: J Reprod Immunol
Title: Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific.
Volume: 61
Issue: 2
Pages: 67-77
Publication
First Author: Dai X
Year: 2010
Journal: J Histochem Cytochem
Title: Indoleamine 2,3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functions.
Volume: 58
Issue: 1
Pages: 17-28
Publication
First Author: Mellor AL
Year: 2002
Journal: J Immunol
Title: Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.
Volume: 168
Issue: 8
Pages: 3771-6
Publication
First Author: Noh KT
Year: 2013
Journal: Biochem Biophys Res Commun
Title: Resveratrol suppresses tumor progression via the regulation of indoleamine 2,3-dioxygenase.
Volume: 431
Issue: 2
Pages: 348-53
Publication
First Author: Xu H
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation.
Volume: 105
Issue: 18
Pages: 6690-5
Publication  
First Author: Huang YS
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: Pharmacological modulation of T cell immunity results in long-term remission of autoimmune arthritis.
Volume: 118
Issue: 19
Publication
First Author: Blumenthal A
Year: 2012
Journal: PLoS One
Title: M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection.
Volume: 7
Issue: 5
Pages: e37314
Publication
First Author: Mellor AL
Year: 2003
Journal: J Immunol
Title: Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.
Volume: 171
Issue: 4
Pages: 1652-5
Publication  
First Author: Ito D
Year: 2022
Journal: Cell Immunol
Title: d-mannose administration improves autoimmune hepatitis by upregulating regulatory T cells.
Volume: 375
Pages: 104517
Publication
First Author: O'Connor JC
Year: 2009
Journal: J Immunol
Title: Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior.
Volume: 182
Issue: 5
Pages: 3202-12